Impact of immigration status on survival among stage 1 and 2 HER2-positive and triple-negative breast cancer in Ontario, Canada
Fatiregun O, Sutradhar R, Podolsky S, Eisen A, Paszat L, Rakovitch E. Cancer Med. 2025; 14(19):e71288.
Fatiregun O, Sutradhar R, Podolsky S, Eisen A, Paszat L, Rakovitch E. Cancer Med. 2025; 14(19):e71288.
Mata DGMM, Sutradhar R, Castelo M, Hahn E, Nguyen L, Rodin D, Fatiregun O, Trebinjac S, Paszat L, Eisen A, Jerzak KJ, Rakovitch E. Breast Cancer Res Treat. 2025 Aug 13 [Epub ahead of print].
Fatiregun O, Sutradhar R, Podolsky S, Eisen A, Paszat L, Rakovitch E. Clin Breast Cancer. 2025; S1526-8209(25)00209-5. Epub 2025 Jul 18.
Butler SJ, Paszat L, Gershon AS. Healthc Q. 2024; 27(3):7-10. Epub 2024 Dec 17.
Hahn E, Sutradhar R, Paszat L, Nguyen L, Rodin D, Nofech-Mozes S, Trebinjac S, Jerzak KJ, Fong C, Rakovitch E. J Clin Oncol. 2024; JCO2302276. Epub 2024 Jun 28.
O’Brien MA, Paszat L, Makuwaza T, Fong C, Rakovitch E. Curr Oncol. 2024; 31(2):975-86. Epub 2024 Feb 10.
Butler SJ, Louie AV, Sutradhar R, Paszat L, Brooks D, Gershon AS. Transl Lung Cancer Res. 2023; 12(11):2260-74. Epub 2023 Nov 30.
Butler SJ, Louie AV, Sutradhar R, Paszat L, Brooks D, Gershon AS. J Pain Symptom Manage. 2023; Aug 22 [Epub ahead of print].
Castelo M, Paszat L, Hansen BE, Scheer AS, Faught N, Nguyen L, Baxter NN. JAMA Netw Open. 2023; 6(8):e2327109. Epub 2023 Aug 3.
Butler SJ, Louie AV, Sutradhar R, Paszat L, Brooks D, Gershon AS. Curr Oncol. 2023; 30(7):6397-410. Epub 2023 Jul 5.